Division of Allergy and Immunology, Nationwide Children's Hospital and The Ohio State University College of Medicine, 700 Children's Drive, Columbus, OH, 43205, USA.
Curr Allergy Asthma Rep. 2021 Apr 7;21(4):28. doi: 10.1007/s11882-021-01006-x.
To provide clinicians with an understanding of risk factors associated with fatal anaphylaxis, and to promote individualized management plans with patients based upon key aspects of their clinical history.
While anaphylaxis can affect a significant percentage of the general population, death from anaphylaxis remains a rare outcome. The presence of asthma and peanut or tree nut allergy is associated with higher risk for severe or fatal anaphylaxis from foods. Specific triggers (medications, venom), underlying comorbid conditions, age, and use of some medications can also impact risk and warrant different counseling and management strategies. Anaphylaxis is a rapidly progressive systemic reaction with multiple different causes and encompasses a wide degree of severity in clinical presentation and risk for future episodes. Individualized management, discussion of risk, and shared decision making should occur with each patient and in consideration of their personal risk factors.
为临床医生提供与致命性过敏反应相关的危险因素的理解,并根据患者临床病史的关键方面为其制定个体化管理计划。
尽管过敏反应可能影响相当一部分人群,但过敏反应导致死亡仍是罕见的。哮喘和花生或树坚果过敏的存在与食物引起的严重或致命过敏反应风险增加相关。特定的触发因素(药物、毒液)、潜在的合并症、年龄以及某些药物的使用也会影响风险,需要不同的咨询和管理策略。过敏反应是一种快速进展的全身性反应,有多种不同的原因,临床表现和未来发作的风险范围广泛。应根据每位患者的个人风险因素进行个体化管理、风险讨论和共同决策。